Tamoxifen non-compliance: does it matter?

Lancet Oncol. 2002 Nov;3(11):654. doi: 10.1016/s1470-2045(02)00895-1.
No abstract available

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Breast Neoplasms / drug therapy*
  • Data Collection
  • Drug Administration Schedule
  • Female
  • Humans
  • Incidence
  • Patient Compliance*
  • Tamoxifen / administration & dosage*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Phytogenic
  • Tamoxifen